QC
EW icon

QCM Cayman’s Edwards Lifesciences EW Stock Holding History

QCM Cayman’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,197
Closed -$214K – 60
2018
Q4 		$214K Buy
+4,197
New +$212K 0.87% 57
2017
Q4 		– Sell
-7,164
Closed -$261K – 156
2017
Q3 		$261K Buy
+7,164
New +$273K 0.67% 65
2016
Q1 		– Sell
-8,013
Closed -$211K – 208
2015
Q4 		$211K Buy
+8,013
New +$208K 0.17% 99

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

QCM Cayman's EW Position: Q1 2019 in Review

QCM Cayman sold out of Edwards Lifesciences (EW) in Q1 2019, closing a stake of 4,197 shares — an estimated $214K sold.

QCM Cayman first reported a position in EW in Q4 2015 and held it in 3 quarters. The position peaked at $261K in Q3 2017. 923 funds tracked by Wall St. Rank hold EW as of Q1 2019.

  • QCM Cayman reported no remaining Edwards Lifesciences position as of Q1 2019 after selling out during the quarter.
  • QCM Cayman sold 4,197 Edwards Lifesciences shares in Q1 2019, an estimated $214K.
  • QCM Cayman first reported a position in Edwards Lifesciences in Q4 2015 and held it in 3 quarters.
  • QCM Cayman's Edwards Lifesciences position peaked at $261K in Q3 2017.
  • 923 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on QCM Cayman's 13F filing for Q1 2019, filed 13 May 2019.